Accessibility Menu

Better Buy: IBM vs. Kyndryl

Should you invest in Big Blue or its newly minted spin-off?

By Leo Sun Jan 22, 2022 at 6:10AM EST

Key Points

  • IBM spun off Kyndryl last November.
  • Big Blue’s investors were eager to dump the new spin-off.
  • IBM might generate more stable growth without Kyndryl, but Kyndryl is also deeply undervalued as a standalone investment.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.